1887

n South African Medical Journal - Big pharma under the spotlight : editorial

Volume 103, Issue 6
  • ISSN : 0256-9574
USD

 

Abstract

In February 2013, in what the called a 'spectacular public relations coup', Andrew Witty, the chief executive officer of GlaxoSmithKline (GSK), announced that the company would sign up to AllTrials - a campaign that has been pressing drug companies to disclose detailed clinical study reports and drug trial results, not just those with favourable results.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_samj/103/6/EJC136327
2013-06-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error